Scottsdale, Arizona (Newsfile Corp. - March 18, 2022) - Sibannac, Inc. (OTC Pink: SNNC), a Nevada corporation (the "Company"), announced the following:With Eric Stoll coming aboard as the Company's Chief
Pharmaceutical company GlaxoSmithKline (GSK) on Tuesday announced positive results from a phase three trial of its plant-based coronavirus vaccine, the first inoculant of its kind to reach a stage to seek emergency approval.
[PDF] Plant-based Vaccines Market Continues to Expand Effective Alternative to Conventional Vaccines pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
The Plantbased Vaccines Market to record growth upfront in the next decade pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.